Home › Therapeutic areas › Neurology › Progressive Supranuclear Palsy

Progressive Supranuclear Palsy (2 companies)

Companies with an active program in Progressive Supranuclear Palsy.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ACIU AC Immune Neurology Rare 1 Phase 3 $210M 11
ARVN Arvinas NeurologyOncology Rare 1 Approved $447M 10